Status | Study |
Completed |
Study Name: Tolerability, Safety and Efficacy of Lubricin (150 µg/ml) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops in Patients With Moderate Dry Eye (DE) Condition: Dry Eye Syndrome Date: 2015-07-23 Interventions: Device: Lubricin Lubricin 150 |
Completed |
Study Name: Safety and Efficacy of PG101 for Dry Eye Syndrome Condition: Dry Eye Syndrome Date: 2013-12-20 Interventions: Drug: PG101 A topical gel containing either 1% or 0.25% PG101 active. |
Withdrawn |
Study Name: Pilot Study to Clinical Evaluate Device Prototypes in Dry Eye Patients Condition: Dry Eye Syndrome Date: 2013-09-30 Interventions: Device: Lacrima medical Prototypes |
Completed |
Study Name: Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes Condition: Dry Eye Syndromes Date: 2013-02-27 Interventions: Drug: Haporine-S 1 or 2 drops |
Completed |
Study Name: A Multi-Center Study Subjects With Dry Eye Syndrome Condition: Dry Eye Syndrome Date: 2012-12-04 Interventions: Drug: EBI-005-2 The investigational drug EBI-005-2, is an intervention to three different study arms. On |
Completed |
Study Name: Efficacy and Safety of a Treatment for Dry Eye Syndrome: Thealoz Condition: Moderate Dry Eye Syndrome Date: 2012-12-04 Interventions: Other: Thealoz Instillation of |
Completed |
Study Name: A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes Condition: Dry Eye Syndromes Date: 2012-09-20 Interventions: Drug: KCT-0809 Drug: Placebo |
Completed |
Study Name: Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome Condition: Dry Eye Syndrome Date: 2012-02-20 Interventions: Drug: PRO-148 Ophthalmic Solution |
Completed |
Study Name: Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome Condition: Dry Eye Syndrome Date: 2012-01-19 Interventions: Drug: DA-6034 3% Eye drop, 1 d |
Completed |
Study Name: A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome Condition: Dry Eye Syndromes Date: 2011-09-01 Interventions: Drug: KCT-0809 Drug: Placebo |